Workflow
雪榕生物:9月23日召开董事会会议

Group 1 - The company, Xuerong Biotechnology, held its 33rd meeting of the 5th Board of Directors on September 23, 2025, in Shanghai [1] - The meeting reviewed a proposal regarding the company's application for comprehensive credit from banks and the continuation of providing collateral guarantees [1] Group 2 - The industry is currently facing heightened scrutiny regarding bidding processes, particularly in large-scale national procurement, leading to increased requirements for bidders to justify their pricing [1]